Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air^® real‐world data

Abstract

Allergic rhinitis medication patterns are similar across European regions. One third of treatment days involved co-medication. These findings suggest that patients treat themselves according to their symptoms (irrespective of how they understand AR) and that co-medication use is driven by symptom severity.